Communication Nursing Homes Vaccines 
Eye on FDA
AUGUST 8, 2022
In February 2020 I published a blog posting – Emerging Pathogens, Communications – that encapsulated my observations and learnings from my years work in the early years of the HIV/AIDS pandemic in the early 1980s. And when it comes to communications challenges there are many commonalities. Source: CDC. What to Do.
Pharmaceutical Technology
MAY 1, 2023
After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?
Expert insights. Personalized for you.
93 
Let's personalize your content